home / stock / adap / adap short
Short Information | Adaptimmune Therapeutics plc (NASDAQ:ADAP)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 4,965,125 |
Total Actual Volume | 26,157,474 |
Short Trends | |
---|---|
Cover Days | 20 |
Short Days | 0 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 248,256 |
Average Short Percentage | 19.46% |
Is there a ADAP Short Squeeze or Breakout about to happen?
See the ADAP Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
04-25-2024 | $1.05 | $1.06 | $1.0992 | $1.04 | 565,527 | 110,257 | 19.5% |
04-24-2024 | $1.14 | $1.08 | $1.15 | $1.07 | 777,793 | 172,192 | 22.14% |
04-23-2024 | $1.04 | $1.14 | $1.16 | $1 | 1,131,087 | 212,142 | 18.76% |
04-22-2024 | $0.99 | $1.01 | $1.08 | $0.94 | 694,255 | 143,302 | 20.64% |
04-19-2024 | $0.9201 | $0.9767 | $1.1 | $0.920001 | 1,482,450 | 285,329 | 19.25% |
04-18-2024 | $0.9676 | $0.8984 | $0.9893 | $0.8721 | 3,345,633 | 543,375 | 16.24% |
04-17-2024 | $1.02 | $0.987 | $1.045 | $0.9301 | 1,222,265 | 239,535 | 19.6% |
04-16-2024 | $1.05 | $1.03 | $1.06 | $0.9801 | 1,224,206 | 161,733 | 13.21% |
04-15-2024 | $1.2 | $1.05 | $1.21 | $1.05 | 1,324,308 | 199,170 | 15.04% |
04-12-2024 | $1.2 | $1.16 | $1.2799 | $1.13 | 3,079,437 | 585,986 | 19.03% |
04-11-2024 | $1.28 | $1.29 | $1.34 | $1.26 | 882,268 | 174,882 | 19.82% |
04-10-2024 | $1.33 | $1.27 | $1.33 | $1.25 | 1,514,980 | 327,723 | 21.63% |
04-09-2024 | $1.36 | $1.37 | $1.405 | $1.35 | 718,236 | 133,003 | 18.52% |
04-08-2024 | $1.4 | $1.36 | $1.41 | $1.33 | 1,025,092 | 189,319 | 18.47% |
04-05-2024 | $1.39 | $1.37 | $1.42 | $1.32 | 1,205,337 | 206,915 | 17.17% |
04-04-2024 | $1.41 | $1.35 | $1.45 | $1.35 | 777,369 | 163,292 | 21.01% |
04-03-2024 | $1.4 | $1.38 | $1.42 | $1.35 | 1,636,265 | 253,515 | 15.49% |
04-02-2024 | $1.46 | $1.4 | $1.46 | $1.36 | 1,148,290 | 349,564 | 30.44% |
04-01-2024 | $1.55 | $1.47 | $1.55 | $1.45 | 1,334,215 | 259,488 | 19.45% |
03-28-2024 | $1.65 | $1.58 | $1.65 | $1.53 | 1,068,461 | 254,403 | 23.81% |
News, Short Squeeze, Breakout and More Instantly...
Adaptimmune Therapeutics plc Company Name:
ADAP Stock Symbol:
NASDAQ Market:
Company remains focused on launching afami-cel later this year with a PDUFA date of August 4 th and developing its broader sarcoma franchise Update on afami-cel launch plans to be provided at the April 18 th Investor Day Philadelphia, Pennsylvania and Oxford, United Kindgom--(Newsfile Corp. -...
Philadelphia, Pennsylvania and Oxford, United Kindgom--(Newsfile Corp. - March 27, 2024) - Adaptimmune Therapeutics plc (NASDAQ: ADAP), a company redefining the treatment of solid tumor cancers with cell therapy, today announced that The Lancet published the company's pivotal Phase 2 data with ...
Shares of Marvell Technology, Inc. (NASDAQ: MRVL) fell sharply during Friday’s session after the company reported fourth-quarter financial r...